US Stock MarketDetailed Quotes

Oric Pharmaceuticals (ORIC)

Watchlist
  • 10.750
  • +0.520+5.08%
Close Apr 17 16:00 ET
  • 10.780
  • +0.030+0.28%
Post 20:01 ET
1.20BMarket Cap-7.31P/E (TTM)

Oric Pharmaceuticals (ORIC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.50%-110.97M
19.86%-22.48M
12.80%-25.11M
-20.36%-30.84M
-7.78%-32.53M
-31.48%-112.66M
-15.59%-28.05M
-46.59%-28.8M
-21.19%-25.63M
-46.34%-30.19M
Net income from continuing operations
-1.27%-129.47M
15.98%-30.51M
5.73%-32.59M
-13.74%-36.36M
-20.03%-30.02M
-26.96%-127.85M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
Depreciation and amortization
10.21%1.22M
5.26%320K
6.67%288K
13.97%310K
15.71%302K
7.27%1.11M
15.59%304K
5.06%270K
5.02%272K
3.16%261K
Change In working capital
-377.39%-5.46M
-62.01%1.66M
-10.30%2.14M
-123.17%-780K
-3.91%-8.49M
-59.82%1.97M
120.77%4.38M
-34.26%2.39M
426.48%3.37M
-2,726.05%-8.17M
-Change in prepaid assets
1,149.65%1.79M
55.98%2.11M
-52.08%782K
-22.58%-532K
76.13%-575K
-91.17%143K
34.73%1.35M
689.17%1.63M
-105.69%-434K
-318.40%-2.41M
-Change in payables and accrued expense
-497.04%-7.25M
-114.81%-448K
79.79%1.36M
-106.53%-248K
-37.39%-7.91M
-44.33%1.83M
209.09%3.03M
-80.64%757K
563.41%3.8M
-627.02%-5.76M
Cash from discontinued investing activities
Operating cash flow
1.50%-110.97M
19.86%-22.48M
12.80%-25.11M
-20.36%-30.84M
-7.78%-32.53M
-31.48%-112.66M
-15.59%-28.05M
-46.59%-28.8M
-21.19%-25.63M
-46.34%-30.19M
Investing cash flow
Cash flow from continuing investing activities
-768.70%-148.03M
-60.18%16.98M
-579.13%-110.54M
-520.84%-76.93M
136.29%22.45M
151.00%22.14M
103.48%42.66M
139.89%23.07M
194.65%18.28M
-584.18%-61.87M
Net PPE purchase and sale
40.07%-712K
-3.65%-227K
91.63%-35K
81.08%-63K
-77.52%-387K
-39.93%-1.19M
-284.21%-219K
-442.86%-418K
17.78%-333K
29.68%-218K
Net investment purchase and sale
-731.59%-147.32M
-59.86%17.21M
-570.45%-110.5M
-512.97%-76.87M
137.04%22.84M
154.81%23.33M
103.97%42.87M
140.67%23.49M
198.44%18.61M
-571.04%-61.65M
Cash from discontinued investing activities
Investing cash flow
-768.70%-148.03M
-60.18%16.98M
-579.13%-110.54M
-520.84%-76.93M
136.29%22.45M
151.00%22.14M
103.48%42.66M
139.89%23.07M
194.65%18.28M
-584.18%-61.87M
Financing cash flow
Cash flow from continuing financing activities
93.81%245.26M
160.87%1.5M
86,765.87%109.45M
16,358.58%134.3M
-99.99%11K
47.74%126.55M
26.93%575K
306.45%126K
-99.04%816K
125.03M
Net common stock issuance
95.50%244.37M
--0
--110.44M
--133.93M
--0
47.06%125M
--0
--0
--0
--125M
Proceeds from stock option exercised by employees
91.95%3.29M
160.87%1.5M
493.65%748K
-3.06%791K
27.78%253K
93.79%1.72M
26.65%575K
306.45%126K
104.00%816K
--198K
Net other financing activities
-1,326.79%-2.4M
--0
---1.74M
---414K
-44.05%-242K
25.99%-168K
--0
--0
--0
---168K
Cash from discontinued financing activities
Financing cash flow
93.81%245.26M
160.87%1.5M
86,765.87%109.45M
16,358.58%134.3M
-99.99%11K
47.74%126.55M
26.93%575K
306.45%126K
-99.04%816K
--125.03M
Net cash flow
Beginning cash position
150.88%59.9M
12.16%50.16M
51.73%76.36M
-12.36%49.83M
150.88%59.9M
-64.53%23.88M
67.31%44.72M
-51.69%50.32M
-4.38%56.85M
-64.53%23.88M
Current changes in cash
-138.14%-13.74M
-126.35%-4M
-367.70%-26.2M
506.34%26.53M
-130.54%-10.07M
182.94%36.02M
631.74%15.18M
92.77%-5.6M
-114.60%-6.53M
520.08%32.98M
End cash Position
-22.93%46.16M
-22.93%46.16M
12.16%50.16M
51.73%76.36M
-12.36%49.83M
150.88%59.9M
150.88%59.9M
67.31%44.72M
-51.69%50.32M
-4.38%56.85M
Free cash flow
1.90%-111.68M
19.68%-22.71M
13.92%-25.15M
-19.06%-30.91M
-8.28%-32.92M
-31.56%-113.85M
-16.22%-28.27M
-48.13%-29.22M
-20.45%-25.96M
-45.21%-30.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.50%-110.97M19.86%-22.48M12.80%-25.11M-20.36%-30.84M-7.78%-32.53M-31.48%-112.66M-15.59%-28.05M-46.59%-28.8M-21.19%-25.63M-46.34%-30.19M
Net income from continuing operations -1.27%-129.47M15.98%-30.51M5.73%-32.59M-13.74%-36.36M-20.03%-30.02M-26.96%-127.85M-28.16%-36.31M-35.67%-34.57M-39.31%-31.96M-4.45%-25.01M
Depreciation and amortization 10.21%1.22M5.26%320K6.67%288K13.97%310K15.71%302K7.27%1.11M15.59%304K5.06%270K5.02%272K3.16%261K
Change In working capital -377.39%-5.46M-62.01%1.66M-10.30%2.14M-123.17%-780K-3.91%-8.49M-59.82%1.97M120.77%4.38M-34.26%2.39M426.48%3.37M-2,726.05%-8.17M
-Change in prepaid assets 1,149.65%1.79M55.98%2.11M-52.08%782K-22.58%-532K76.13%-575K-91.17%143K34.73%1.35M689.17%1.63M-105.69%-434K-318.40%-2.41M
-Change in payables and accrued expense -497.04%-7.25M-114.81%-448K79.79%1.36M-106.53%-248K-37.39%-7.91M-44.33%1.83M209.09%3.03M-80.64%757K563.41%3.8M-627.02%-5.76M
Cash from discontinued investing activities
Operating cash flow 1.50%-110.97M19.86%-22.48M12.80%-25.11M-20.36%-30.84M-7.78%-32.53M-31.48%-112.66M-15.59%-28.05M-46.59%-28.8M-21.19%-25.63M-46.34%-30.19M
Investing cash flow
Cash flow from continuing investing activities -768.70%-148.03M-60.18%16.98M-579.13%-110.54M-520.84%-76.93M136.29%22.45M151.00%22.14M103.48%42.66M139.89%23.07M194.65%18.28M-584.18%-61.87M
Net PPE purchase and sale 40.07%-712K-3.65%-227K91.63%-35K81.08%-63K-77.52%-387K-39.93%-1.19M-284.21%-219K-442.86%-418K17.78%-333K29.68%-218K
Net investment purchase and sale -731.59%-147.32M-59.86%17.21M-570.45%-110.5M-512.97%-76.87M137.04%22.84M154.81%23.33M103.97%42.87M140.67%23.49M198.44%18.61M-571.04%-61.65M
Cash from discontinued investing activities
Investing cash flow -768.70%-148.03M-60.18%16.98M-579.13%-110.54M-520.84%-76.93M136.29%22.45M151.00%22.14M103.48%42.66M139.89%23.07M194.65%18.28M-584.18%-61.87M
Financing cash flow
Cash flow from continuing financing activities 93.81%245.26M160.87%1.5M86,765.87%109.45M16,358.58%134.3M-99.99%11K47.74%126.55M26.93%575K306.45%126K-99.04%816K125.03M
Net common stock issuance 95.50%244.37M--0--110.44M--133.93M--047.06%125M--0--0--0--125M
Proceeds from stock option exercised by employees 91.95%3.29M160.87%1.5M493.65%748K-3.06%791K27.78%253K93.79%1.72M26.65%575K306.45%126K104.00%816K--198K
Net other financing activities -1,326.79%-2.4M--0---1.74M---414K-44.05%-242K25.99%-168K--0--0--0---168K
Cash from discontinued financing activities
Financing cash flow 93.81%245.26M160.87%1.5M86,765.87%109.45M16,358.58%134.3M-99.99%11K47.74%126.55M26.93%575K306.45%126K-99.04%816K--125.03M
Net cash flow
Beginning cash position 150.88%59.9M12.16%50.16M51.73%76.36M-12.36%49.83M150.88%59.9M-64.53%23.88M67.31%44.72M-51.69%50.32M-4.38%56.85M-64.53%23.88M
Current changes in cash -138.14%-13.74M-126.35%-4M-367.70%-26.2M506.34%26.53M-130.54%-10.07M182.94%36.02M631.74%15.18M92.77%-5.6M-114.60%-6.53M520.08%32.98M
End cash Position -22.93%46.16M-22.93%46.16M12.16%50.16M51.73%76.36M-12.36%49.83M150.88%59.9M150.88%59.9M67.31%44.72M-51.69%50.32M-4.38%56.85M
Free cash flow 1.90%-111.68M19.68%-22.71M13.92%-25.15M-19.06%-30.91M-8.28%-32.92M-31.56%-113.85M-16.22%-28.27M-48.13%-29.22M-20.45%-25.96M-45.21%-30.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More